Antigen-specific toxins may offer hope as AIDS therapy
Antigen-specific toxins may offer hope as AIDS therapy
A new class of antigen-specific killer cells may offer a new, effective form of treatment for HIV. Researchers at Wake Forest University in Winston-Salem, NC, have produced HIV-specific killer cells by genetically modifying lymphocytes to target HIV-infected cells in vivo. Preclinical tests indicate that immunotoxins are effective in treating tumor cells and virally infected cells, but that when actually used in humans, the toxins may cause toxicity or anaphylaxis. Further research is needed before the new treatment can be given to humans, the investigators say.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.